GCG and type 2 diabetes mellitus: In a transgenic rat model of type 2 diabetes mellitus, DPP-IV inhibition by sitagliptin increased ductal cell proliferation and induced ductal cell metaplasia as a precursor of pancreatic ductal adenocarcinoma, possibly due to the increased availability of GLP-1 [89].